Accepted at 12:34 p.m. Oct, 09, 2024 by beejumm
Author: beejumm
Related Note: 1488768082952 1
Rationale for change

Think this should be added as a cloze, as this was the tested point on both UW qid 4452 and qid 6881

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::16_Neuro::03_Neurovascular_Disorders::06_Treatment_of_TIA/Stroke::Extra #AK_Step1_v12::#UWorld::COMLEX::26286 #AK_Step2_v12::#UWorld::Step::4452 #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::02_Warfarin_(MOA,_Indications,_AR,_CI) #AK_Step2_v12::#SketchyNeurology::07_Neurovascular::04_Stroke_Management::01_Ischemic_Stroke_Treatment #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::04_Tachycardia::04_Narrow_Complex_Tachycardia:_AFib_&_AFlutter_Management #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step2_v12::#UWorld::Step::6881 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::09_Factor_Xa_Inhibitors_(Apixaban/Rivaroxaban/Edoxaban) #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #PANCE::EOR::Family_med #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::04_Direct_coagulation_factor_inhibitors::*Direct_Factor_Xa_Inhibitors #PANCE::CARDIO::conduction_disorders/dysrhythmias #AK_Step1_v12::#Textbooks::#Blumenfeld_Neuroanatomy::10_Cerebral_Hemispheres_and_Vascular_Supply #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::23_Pharmacology_Of_Hemostasis_and_Thrombosis #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::04_Direct_Acting_Oral_Anticoagulants_(DOACs)_(MOA,_Indications,_AR,_CI) #AK_Step2_v12::#UWorld::COMLEX::101238 #PANCE::EOR::IM #AK_Step2_v12::#SketchyNeurology::07_Neurovascular::02_Ischemic_Stroke::01_Ischemic_Embolic_Stroke #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants::Extra #AK_Step2_v12::#Bootcamp::Medicine::01_Cardiology::02_Valvular_Disease::11_Complications_and_Critical_Interventions #AK_Step2_v12::#AMBOSS::7C04tR #AK_Step2_v12::#AMBOSS::TB06Zi #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::03_Heparin_(MOA,_Indications,_ADR,_CI) #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter #AK_Step2_v12::#UWorld::Step::4649 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::02_DirectThrombinInhibitors_DirectFactorXaInhibitors #AK_Other::Only_Step_1&2_Overlap #PANCE::EOR::EM #AK_Step2_v12::!Shelf::IM #AK_Step1_v12::#UWorld::Step::15390 #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::05_Retired_Lessons::04_Tachycardia::02_Narrow_Complex_Tachycardia_AFib_AFlutter_SOA_MAT_SOAP_[OLD_VERSION] #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics